• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MLL-AF9 介导的人类造血细胞沿着不同谱系的永生化在个体发生过程中发生变化。

MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.

机构信息

Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

Leukemia. 2013 Apr;27(5):1116-26. doi: 10.1038/leu.2012.343. Epub 2012 Nov 26.

DOI:10.1038/leu.2012.343
PMID:23178754
Abstract

The MLL-AF9 fusion gene is associated with aggressive leukemias of both the myeloid and lymphoid lineage in infants, whereas in adults, this translocation is mainly associated with acute myeloid leukemia. These observations suggest that differences exist between fetal and adult tissues in terms of the 'cell of origin' from which the leukemia develops. Here we show that depending on extrinsic cues, human neonatal CD34(+) cells are readily immortalized along either the myeloid or lymphoid lineage upon MLL-AF9 expression and give rise to mainly lymphoid leukemia in immunocompromised mice. In contrast, immortalization of adult bone marrow CD34(+) cells is more difficult to achieve and is myeloid-biased, even when MLL-AF9 is expressed in purified hematopoietic stem cells (HSCs). Transcriptome analysis identified enrichment of HSC but not progenitor gene signatures in MLL-AF9-expressing cells. Although not observed in adult cells, neonatal cells expressing MLL-AF9 were enriched for gene signatures associated with poor prognosis, resistance to chemotherapeutic agents and MYC signaling. These results indicate that neonatal cells are inherently more prone to MLL-AF9-mediated immortalization than adult cells and suggest that intrinsic properties of the cell of origin, in addition to extrinsic cues, dictate lineage of the immortalized cell.

摘要

MLL-AF9 融合基因与婴儿的髓系和淋巴系侵袭性白血病有关,而在成人中,这种易位主要与急性髓系白血病有关。这些观察结果表明,胎儿和成人组织在白血病起源的“细胞”方面存在差异。在这里,我们表明,取决于外在线索,人新生儿 CD34+细胞在表达 MLL-AF9 后很容易沿着髓系或淋巴系无限增殖,并在免疫缺陷小鼠中主要引发淋巴性白血病。相比之下,成人骨髓 CD34+细胞的永生化更难实现,并且偏向髓系,即使在纯化的造血干细胞 (HSCs) 中表达 MLL-AF9 也是如此。转录组分析鉴定出在表达 MLL-AF9 的细胞中富集了 HSC 而不是祖细胞基因特征。尽管在成人细胞中未观察到,但表达 MLL-AF9 的新生儿细胞富含与预后不良、对化疗药物和 MYC 信号的抗性相关的基因特征。这些结果表明,新生儿细胞比成人细胞更容易受到 MLL-AF9 介导的永生化,并且表明除了外在线索之外,起源细胞的内在特性决定了永生化细胞的谱系。

相似文献

1
MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.MLL-AF9 介导的人类造血细胞沿着不同谱系的永生化在个体发生过程中发生变化。
Leukemia. 2013 Apr;27(5):1116-26. doi: 10.1038/leu.2012.343. Epub 2012 Nov 26.
2
Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.在MLL重排的人类急性淋巴细胞白血病中鉴定CD34 +和CD34 -白血病起始细胞。
Blood. 2015 Feb 5;125(6):967-80. doi: 10.1182/blood-2014-03-563304. Epub 2014 Dec 23.
3
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.ZNF521 通过改变基因表达图谱增强 MLL-AF9 依赖性急性髓系白血病中的造血干细胞转化。
Int J Mol Sci. 2021 Oct 6;22(19):10814. doi: 10.3390/ijms221910814.
4
Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.微环境决定MLL - AF9白血病人类模型中的谱系命运。
Cancer Cell. 2008 Jun;13(6):483-95. doi: 10.1016/j.ccr.2008.04.020.
5
The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.AAA+ ATPase RUVBL2 是 MLL-AF9 致癌作用的关键介质。
Leukemia. 2013 Jul;27(7):1461-8. doi: 10.1038/leu.2013.42. Epub 2013 Feb 13.
6
MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.MLL-AF9与FLT3在急性髓性白血病中的协同作用:一种用于快速治疗评估模型的建立
Leukemia. 2008 Jan;22(1):66-77. doi: 10.1038/sj.leu.2404951. Epub 2007 Sep 13.
7
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.EVI1 对于一小部分 MLL-AF9 重排 AML 的发病机制至关重要。
Blood. 2012 Jun 14;119(24):5838-49. doi: 10.1182/blood-2011-11-393827. Epub 2012 May 2.
8
An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.插入性诱变筛选确定了与 Mll-AF9 在小鼠白血病发病模型中协同作用的基因。
Blood. 2012 May 10;119(19):4512-23. doi: 10.1182/blood-2010-04-281428. Epub 2012 Mar 16.
9
MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?MLL-AF9白血病干细胞:是固有特性还是受微环境影响?
Cancer Cell. 2008 Jun;13(6):465-7. doi: 10.1016/j.ccr.2008.05.012.
10
Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia.强制表达脐带血 CD34+ 细胞中的 MLL-AF4 融合基因可增强造血重建造血细胞功能和集落形成能力,但不足以引发白血病。
Blood. 2011 May 5;117(18):4746-58. doi: 10.1182/blood-2010-12-322230. Epub 2011 Mar 9.

引用本文的文献

1
Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia.新型Menin-KMT2A抑制剂JNJ-75276617(即Bleximenib)可损害急性髓系白血病的长期增殖和免疫逃逸能力。
Haematologica. 2025 Jun 1;110(6):1278-1291. doi: 10.3324/haematol.2024.285616. Epub 2024 Dec 19.
2
Acute myeloid leukemia associated RUNX1 variants induce aberrant expression of transcription factor TCF4.急性髓系白血病相关的RUNX1变体诱导转录因子TCF4的异常表达。
Leukemia. 2025 Feb;39(2):520-523. doi: 10.1038/s41375-024-02470-w. Epub 2024 Dec 12.
3
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development.
白血病发展过程中克隆进化、分化层次和个体发生的交叉点
Blood Cancer Discov. 2025 Mar 4;6(2):94-109. doi: 10.1158/2643-3230.BCD-24-0235.
4
HMX3 is a critical vulnerability in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia.HMX3是MECOM阴性KMT2A::MLLT3急性粒单核细胞白血病中的一个关键漏洞。
Leukemia. 2025 Feb;39(2):371-380. doi: 10.1038/s41375-024-02485-3. Epub 2024 Dec 4.
5
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression.LIN28B促进完全转化的急性髓系白血病细胞的分化,但对胎儿白血病的抑制作用并非必需。
Leukemia. 2024 Mar;38(3):648-651. doi: 10.1038/s41375-024-02167-0. Epub 2024 Feb 6.
6
Understanding blood development and leukemia using sequencing-based technologies and human cell systems.利用基于测序的技术和人类细胞系统来理解血液发育和白血病。
Front Mol Biosci. 2023 Oct 10;10:1266697. doi: 10.3389/fmolb.2023.1266697. eCollection 2023.
7
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation.不依赖造血干细胞(HSC)的祖细胞易受Mll-Af9诱导的白血病转化影响。
Cancers (Basel). 2023 Jul 14;15(14):3624. doi: 10.3390/cancers15143624.
8
Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.诱导型 MLL-AF9 表达在人多能干细胞源性造血分化过程中驱动 AML 发生。
Cells. 2023 Apr 20;12(8):1195. doi: 10.3390/cells12081195.
9
Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation.层状免疫和层状白血病形成:小儿白血病起始的发育受限机制。
Immunol Rev. 2023 May;315(1):197-215. doi: 10.1111/imr.13180. Epub 2023 Jan 2.
10
Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia.急性髓系白血病中MEF2D-IRF8转录回路依赖性的剖析
iScience. 2022 Sep 15;25(10):105139. doi: 10.1016/j.isci.2022.105139. eCollection 2022 Oct 21.